ONS antibody survey, May 18th
[ Ссылка ]
19th April
69.3% in England
63.2% in Wales
63.5% in Northern Ireland
59.2% in Scotland
Highest in the older age groups across the UK
Similar across English regions,
64.8% in the South West to
69.7% in the North West.
Infection or vaccination?
Vaccinations now
[ Ссылка ]
First dose 69.9 %
Second dose 39.0 %
Positive tests
Down 2.6% in past 7 days
Next stage of roadmap
[ Ссылка ]
Government, clearer idea of India variant threat
in a few days’ time
21st June?
Bolton
Highest infection rate in UK
Hospitalised
2 weeks ago, 13
Today, 24
India
[ Ссылка ]
Deaths, + 4,329
Highest so far
A 'massive' discrepancy in the death toll
[ Ссылка ]
Unlikely to resume vaccines exports until at least October
COVAX implications
Cyclone
Gujarat, patients cleared to 5 km from cost
Mumbai moved 600 Covid-19 patients from field hospitals
Two people have died in
Nepal
Taiwan
Cases, + 206 + 335 + 240 = 2,257
Deaths, + 2
All schools closed until June
Egypt
Prioritising vaccination of tourism workers
Fully vaccinating two resort areas
Germany
Offering vaccines to all adults from 7 June
Delaying second Pfizer vaccines
Birmingham University
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
12 weeks significantly increases antibody responses in older people
175 vaccine recipients older than 80
Received second dose of Pfizer
Either 3 weeks or 11–12 weeks after first dose
Outcomes, levels of antibodies against the SARS-CoV-2 spike protein
T cells
Peak antibody levels were 3.5 times higher
12 weeks versus 3 weeks
Peak T-cell response was lower in 12 week group
But antibodies maintained for 9 weeks after second vaccine
(Other countries may have different vaccines and variants and social conditions)
Stephen Griffin, virologist, University of Leeds
People are theoretically vulnerable between their first and second jab
What’s worked in the UK is maintaining restrictions at the same time as vaccinating
